Delivery Order SPE2DR25D3501-SPE2DR26FL8TS
- Not listed
- The Defense Logistics Agency awarded a $4,992.08 delivery order to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 17, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The Defense Logistics Agency (DLA) awarded a $5,099.04 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on September 25, 2025, with completion targeted for September 26, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supplies to support federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $21,731.92 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location. This delivery order represents a competitive procurement action under the company's...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $3,050.78 under firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $9,681.88 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $14,738.91. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with performance completion targeted for August 7, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger...
- On April 24, 2025, the Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $29,741.91 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance is scheduled for completion by April 25, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,249.10 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order was executed on October 22, 2025, with an ultimate completion date of October 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $25,734.37 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with completion scheduled for September 4, 2025. This contract utilizes a firm fixed price structure and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $11,255.39 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens on September 11, 2025, with an ultimate completion date of September 12, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL8TSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,499.40 on November 14, 2025, for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This competitive award, which carries a firm fixed price structure and an ultimate completion date of November 17, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 vehicle that extends through December 2026 and provides comprehensive pharmaceutical support to military and federal healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, serves as a prime contractor for the Defense Logistics Agency's medical supply chain. The company's extensive portfolio of federal contract awards demonstrates its capacity to supply a wide range of pharmaceutical products and medical supplies, from diabetes medications to specialty treatments, across multiple therapeutic domains. This particular delivery order for insulin reflects AmerisourceBergen's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through its comprehensive pharmaceutical prime vendor agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 11/14/25 |